Endogenous postmenopausal hormones and carotid atherosclerosis: A case-control study of the atherosclerosis risk in communities cohort

American Journal of Epidemiology

Volumn 155, Issue 5, 2002, Pages 437-445

  Golden, Sherita Hill ^a   Maguire, Ann ^b   Ding, Jingzhong ^c   Crouse, J R ^d   Cauley, Jane A ^e   Zacur, Howard ^a   Szklo, Moyses ^c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Androgens; Cardiovascular diseases; Carotid arteries; Estrogen replacement therapy; Estrogens; Postmenopause; Sex hormone binding globulin

Indexed keywords

ANDROSTENEDIONE; ESTRONE; PRASTERONE SULFATE; SEX HORMONE; SEX HORMONE BINDING GLOBULIN;

CARDIOVASCULAR DISEASE; HEALTH RISK; HORMONE; RISK FACTOR; WOMENS HEALTH;

ADULT; ARTERY DIAMETER; ARTICLE; ATHEROSCLEROSIS; B SCAN; CARDIOVASCULAR RISK; CAROTID ARTERY; COHORT ANALYSIS; COMMUNITY; CONTROLLED STUDY; FEMALE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE;

AGED; ANDROSTENEDIONE; ARTERIOSCLEROSIS; CAROTID ARTERY DISEASES; CASE-CONTROL STUDIES; COHORT STUDIES; ESTRONE; FEMALE; HUMANS; MIDDLE AGED; ODDS RATIO; POSTMENOPAUSE; RISK FACTORS; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE;

UNITED STATES;

EID: 0036498976     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/155.5.437     Document Type: Article

References (58)

1. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the Nurses' Health Study
2. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
3. No association of menopause and hormone replacement therapy with carotid artery intima-media thickness
4. Associations of postmenopausal estrogen use with cardiovascular disease and its risk factors in older women
5. Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause
6. Long-term postmenopausal hormone use, obesity, and fat distribution in older women
7. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women
8. The impact of female hormone usage on the lipid profile. The Framingham Offspring Study
9. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial
10. Vascular effects of estrogen and vitamin E therapies in postmenopausal women
11. Carotid plaque regression on oestrogen replacement: A pilot study
12. Exogenous estrogen and endogenous sex hormones
13. Relationship of sex hormone-binding globulin to lipid, lipoprotein, glucose, and insulin concentrations in postmenopausal women
14. Associations of abdominal adiposity, fasting insulin, sex hormone binding globulin, and estrone with lipids and lipoproteins in post-menopausal women
15. Associations of body mass and fat distribution with sex hormone concentrations in postmenopausal women
16. Increased upper body and overall adiposity is associated with decreased sex hormone binding globulin in postmenopausal women
17. Sex hormone-binding globulin and glucose tolerance in postmenopausal women. The Rancho Bernardo Study
18. Postmenopausal hormone therapy
19. Menopause
20. Prospective study of endogenous sex hormones and fatal cardiovascular disease in postmenopausal women
21. A prospective study of sex hormone-binding globulin and fatal cardiovascular disease in Rancho Bernardo men and women
22. The epidemiology of DHEAS and cardiovascular disease
23. Steroid sex hormones and peripheral arterial disease in the Edinburgh Artery Study
24. Serum estrone concentrations and coronary artery disease in postmenopausal women
25. Sex hormones and DHEA-SO4 in relation to ischemic heart disease mortality in diabetic subjects. The Wisconsin Epidemiologic Study of Diabetic Retinopathy
26. Endogenous androgens and carotid intimal-medial thickness in women
27. The Atherosclerosis Risk in Communities (ARIC) study: Design and objectives
28. Estrogen replacement therapy and cognitive functioning in the Atherosclerosis Risk in Communities (ARIC) Study
29. Sex hormone binding globulin: Origin, function and clinical significance
30. Relation of carotid artery wall thickness to diabetes mellitus, fasting glucose and insulin, body size, and physical activity
31. General findings of the International Atherosclerosis Project
32. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
33. ARIC hemostasis study - I. Development of a blood collection and processing system suitable for multicenter hemostatic studies
34. A short questionnaire for the measurement of habitual physical activity in epidemiological studies
35. Polycystic ovary syndrome - From gyneacological curiosity to multisystem endocrinopathy
36. Insulin action in the polycystic ovary syndrome
37. Polycystic ovary syndrome, hyperthecosis and the menopause
38. Dehydroepiandrosterone sulfate does not predict cardiovascular death in postmenopausal women. The Rancho Bernardo Study
39. Relationship between serum sex hormones and coronary artery disease in postmenopausal women
40. Serum sex hormone levels in postmenopausal women with hypertension
41. Relative androgenicity, blood pressure levels, and cardiovascular risk factors in young healthy women
42. Effects of gonadal steroids and their antagonists on DNA synthesis in human vascular cells
43. Testosterone deficiency: A key factor in the increased cardiovascular risk to women following hysterectomy or with natural aging?
44. Relation of sex hormones and dehydroepiandrosterone sulfate (DHEA-SO4) to cardiovascular risk factors in postmenopausal women
45. Relationships and independence of body composition, sex hormones, fat distribution and other cardiovascular risk factors in overweight postmenopausal women
46. Plasma steroid-binding proteins
47. Pathophysiology of sex hormone binding globulin (SHBG): Relation to insulin
48. Insulin sensitivity and atherosclerosis
49. Asymptomatic atherosclerosis and insulin resistance
50. Hypothalamic-pituitary-ovarian axis
51. Physiological importance of dehydroepiandrosterone
52. Fasting plasma glucose levels and endogenous androgens in non-diabetic postmenopausal women
53. Dehydroepiandrosterone, dehydroepiandrosterone sulfate, obesity, waist-hip ratio, and noninsulin-dependent diabetes in postmenopausal women: The Rancho Bernardo Study
54. The role of carotid arterial intima-media thickness in predicting clinical coronary events
55. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: The Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993
56. Reproductive hormone levels in gynecologic oncology patients undergoing surgical castration after spontaneous menopause